Summary : The FDA has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending…
company
-
-
AstraZenecaRegulatoryU.S FDA
FDA says no to AZ’s Fasenra for nasal polyp indication
by adminby adminSummary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
-
Alembic PharmaRegulatoryU.S FDA
Alembic Pharmaceuticals bags USFDA nod for Macitentan tablets
by adminby adminSummary : Alembic Pharmaceuticals received a tentative approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug…
-
Pharma Science & Research
Mutations leading to omicron variant did not enable virus to fully escape immune system
by adminby adminPeople who gained immunity – either through vaccination or exposure – against the original strain of SARS-CoV-2, the virus that causes COVID-19,…
-
Pharma Science & Research
Stealth nanomedicines combat cancer and cut toxic effects of chemo
by adminby adminSynopsis : Nanomedicines – typically drugs hidden within nanoscopic fatty membranes (‘liposomes’) – have potential to transform chemotherapy treatments, improving drug delivery…
-
Pharma Science & ResearchSanofi Inc.
Nirsevimab first potential immunisation to protect against RSV in infants
by adminby adminSynopsis : Nirsevimab has the potential to offer RSV protection for all infants, with a single dose showing 74.5 percent efficacy in…
-
CompaniesPfizer
Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints
by adminby adminSummary : Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended C. difficile infection (CDI), corresponding to 100%…
-
Summary : A new study has found that artificial intelligence (AI) apps helped protect small and medium-sized businesses against many of the…
-
CompaniesCovid DrugsModernaPfizerRegulatoryU.S FDA
Moderna and Pfizer are Well-Positioned to Take mRNA into the Future
by adminby adminSummary : It’s an understatement to note that the bottom lines for Moderna and Pfizer have been fattened by the success of…
-
Covid DrugsRegulatoryU.S FDA
Ocugen Ends Week on Low as FDA Rejects Covaxin EUA for Kids
by adminby adminSummary : The U.S. Food and Drug Administration turned down Ocugen’s Emergency Use Authorization (EUA) request for Covaxin in children 2 to…